Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...

Kenvue, Inc. (KVUE – Research Report), the Technology sector company, was revisited by a Wall Street analyst yesterday. Analyst Anna ...

Two analysts take opposing views on Johnson & Johnson (JNJ) spin-off Kenvue (NYSE ... exacerbated by “organizational inefficiencies,” while Jefferies’ Keith Devas sees an increase in ...

In the assessment of 12-month price targets, analysts unveil insights for Kenvue, presenting an average target of $24.1, a ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Adds Kenvue comment. Kenvue (NYSE:KVUE) needs to focus on fixing its skin, health and beauty segments, Jeff Smith, founder ...

"Care is very much an integral part of [who] we are," she said of Kenvue’s leadership philosophy, which she credits for the organization’s success attracting and retaining top talent ...

By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...

SKILLMAN, N.J., October 17, 2024--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world’s largest pure-play consumer health company by revenue, today announced that its Board of ...

Kenvue (KVUE) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives ...

This is also reflected in the adjusted EPS-based FAST Graphs chart in Figure 6. Kenvue stock currently trades at nearly 20 times earnings, implying a potential return of 8% to 9% if the valuation ...

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is navigating a complex landscape as it establishes itself as an independent entity. The ...